Jason Roszik
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 89
- Cancer Immunotherapy and Biomarkers 32
- CAR-T cell therapy research 24
- Colorectal Cancer Treatments and Studies 13
-
- Melanoma and MAPK Pathways 18
- Co-authors
- Patrick Hwu (18 shared papers)Elizabeth A. Grimm (19 shared papers)Scott E. Woodman (12 shared papers)P. Andrew Futreal (4 shared papers)Chantale Bernatchez (9 shared papers)Lisa Maria Mustachio (19 shared papers)Jennifer A. Wargo (5 shared papers)Vivek Subbiah (32 shared papers)
- Journals
- Journal of Clinical Oncology (22 papers)Cancer Research (12 papers)Cancers (10 papers)Molecular Cancer Therapeutics (10 papers)Clinical Cancer Research (8 papers)
- Partner nations
- United StatesHungaryAustralia
In The Last Decade
Jason Roszik
171 papers receiving 5.5k citations
Jason Roszik's Hit Papers
Peers
Comparison fields: 5 of 147
- Oncology 2.6k
- Immunology 1.9k
- Cancer Research 1.2k
- Molecular Biology 2.3k
- Pulmonary and Respiratory Medicine 799
Countries citing papers authored by Jason Roszik
This map shows the geographic impact of Jason Roszik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Roszik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Roszik more than expected).
Fields of papers citing papers by Jason Roszik
This network shows the impact of papers produced by Jason Roszik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Roszik. The network helps show where Jason Roszik may publish in the future.
Co-authors
The 25 scholars most cited alongside Jason Roszik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 177 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy Hit paper breakdown → | 2016 | 913 |
| 2 | 2017 | 303 | |
| 3 | 2019 | 228 | |
| 4 | 2016 | 196 | |
| 5 | 2014 | 167 | |
| 6 | 2018 | 149 | |
| 7 | 2016 | 117 | |
| 8 | 2018 | 113 | |
| 9 | 2020 | 112 | |
| 10 | 2020 | 86 | |
| 11 | 2021 | 72 | |
| 12 | 2018 | 70 | |
| 13 | 2017 | 64 | |
| 14 | 2018 | 62 | |
| 15 | 2021 | 62 | |
| 16 | 2005 | 59 | |
| 17 | 2017 | 58 | |
| 18 | 2009 | 56 | |
| 19 | 2017 | 54 | |
| 20 | 2008 | 53 |
About Jason Roszik
Jason Roszik is a scholar working on Oncology, Molecular Biology, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 177 papers that have together received 5.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (32 papers), Cancer Genomics and Diagnostics (29 papers), Immunotherapy and Immune Responses (28 papers), CAR-T cell therapy research (24 papers), Melanoma and MAPK Pathways (18 papers), Sarcoma Diagnosis and Treatment (16 papers), Colorectal Cancer Treatments and Studies (13 papers) and Immune Cell Function and Interaction (11 papers). The work is most often cited by research in Oncology (2.6k citations), Immunology (1.9k citations), Cancer Research (1.2k citations), Molecular Biology (2.3k citations) and Pulmonary and Respiratory Medicine (799 citations). Jason Roszik has collaborated with scholars based in United States, Hungary and Australia. Frequent co-authors include Patrick Hwu, Elizabeth A. Grimm, Scott E. Woodman, P. Andrew Futreal, Chantale Bernatchez, Lisa Maria Mustachio, Jennifer A. Wargo, Vivek Subbiah, Yong Qin and Padmanee Sharma. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Cancers, Molecular Cancer Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.